Skip to content
  • Instagram
  • YouTube
  • X

PharmaBR.News

  • About Us

biologics

  • Brazil’s ANVISA expands backlog reduction project for biologics
    17 de March de 2026

    Brazil’s ANVISA expands backlog reduction project for biologics

    pietrorubin
  • Anvisa reports progress in modernization plan and reinforces commitment to reducing regulatory backlog
    25 de November de 2025

    Anvisa reports progress in modernization plan and reinforces commitment to reducing regulatory backlog

    pietrorubin
  • Brazil advances partnership to develop first targeted treatment for yellow fever
    20 de November de 2025

    Brazil advances partnership to develop first targeted treatment for yellow fever

    pietrorubin
  • Special Report – Inside the decision that reshapes Brazil’s Anvisa drug review process
    18 de November de 2025

    Special Report – Inside the decision that reshapes Brazil’s Anvisa drug review process

    pietrorubin
  • Special Report – Inside the decision that reshapes Brazil’s Anvisa drug review process
    11 de November de 2025

    Special Report – Inside the decision that reshapes Brazil’s Anvisa drug review process

    pietrorubin
  • Brazil Anvisa to migrate drug and biologic petitions to the Solicita system
    4 de November de 2025

    Brazil Anvisa to migrate drug and biologic petitions to the Solicita system

    pharmabrnews

Categories

Reviews.

News.

Guides.

Deals.

Videos.

Reader Poll.

Features.

Staff Picks.

Game Culture.

Podcast.

At PharmaBR.News, we highlight key developments in Brazil’s pharmaceutical and health policy landscape.

Get our free weekly briefing straight to your inbox.

  • Instagram
  • YouTube
  • X
  • About Us

Designed with WordPress

Loading Comments...